Zanganeh Mahkam 13D/13G Filings for Summit Therapeutics Inc. (SMMT)

Zanganeh Mahkam 13D and 13G filings for Summit Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-03-13
4:51 pm
Purchase
2023-03-0813DSUMMIT THERAPEUTICS INC
SMMT
Zanganeh Mahkam36,882,393
5.270%
31,399,111increase
(+572.63%)
Filing